Reviews of spinal muscular atrophy in Taiwan

Spinal muscular atrophy (SMA) is one of the rare life-threatening hereditary autosomal recessive disorders. SMA is caused by the absence of a fully functional motor neuron protein gene that produces the survival motor neuron (SMN) protein. The SMN protein is encoded by two SMN genes: SMN1, which is...

Full description

Bibliographic Details
Published in:	Tungs’ Medical Journal
Main Authors:	Yung-Hsiu Lu, Wei-Sheng Lin, Dau-Ming Niu, Ting-Rong Hsu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Subjects:	gene therapy newborn screening spinal muscular atrophy treatment
Online Access:	https://doi.org/10.4103/ETMJ.ETMJ-D-24-00033

Similar Items

Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States
by: Craig M. Zaidman, et al.
Published: (2024-08-01)

Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan
by: Chen-Hua Wang, et al.
Published: (2025-04-01)

Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment
by: Elisa Nigro, et al.
Published: (2023-09-01)

A Five-Year Review of Newborn Screening for Spinal Muscular Atrophy in the State of Utah: Lessons Learned
by: Kristen N. Wong, et al.
Published: (2024-07-01)

Newborn Screening Program for Spinal Muscular Atrophy in the Campania Region (Italy): Current Limitations and Potential Perspectives
by: Adelaide Ambrosio, et al.
Published: (2025-08-01)

Cost analysis of newborn screening for spinal muscular atrophy using digital PCR vs. MLPA
by: Dolat Singh Shekhawat, et al.
Published: (2025-06-01)

One-Year Pilot Study Results of Newborn Screening for Spinal Muscular Atrophy in the Republic of Croatia
by: Darija Šimić, et al.
Published: (2024-07-01)

Spinal muscular atrophy in the era of newborn screening: how the classification could change
by: Antonio Varone, et al.
Published: (2025-05-01)

Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective
by: Michelle A. Farrar, et al.
Published: (2023-11-01)

Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
by: Kshea Hale, et al.
Published: (2021-06-01)

Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan
by: Tomoko Lee, et al.
Published: (2021-08-01)

Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
by: Katarzyna Kotulska, et al.
Published: (2021-10-01)

Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01)

Very severe spinal muscular atrophy (Type 0)
by: Suleiman Al Dakhoul
Published: (2017-01-01)

Results of the Hungarian Newborn Screening Pilot Program for Spinal Muscular Atrophy
by: Krisztina Hegedűs, et al.
Published: (2025-04-01)

The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia
by: Siiri Sarv, et al.
Published: (2021-12-01)

Neonatal Screening for Spinal Muscular Atrophy and Severe T- and B-Cell Lymphopenias in Andalusia: A Prospective Study
by: Beatriz De Felipe, et al.
Published: (2025-01-01)

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
by: Tomokazu Kimizu, et al.
Published: (2021-07-01)

Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience
by: Smilu Mohanlal, et al.
Published: (2025-07-01)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals
by: Ian R. Woodcock, et al.
Published: (2025-04-01)

Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy
by: Katy Cooper, et al.
Published: (2024-07-01)

Massachusetts’ Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
by: Jaime E. Hale, et al.
Published: (2021-05-01)

Spinal Muscular Atrophy: History, Current Status and Future
by: DAI Yi, et al.
Published: (2022-01-01)

Spinal Muscular Atrophy Types, Innovations in Diagnosis and Treatment
by: Hatice Tankisi, et al.
Published: (2023-12-01)

A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check
by: Katerina S. Kucera, et al.
Published: (2021-03-01)

Our Journey from Individual Efforts to Nationwide Support: Implementing Newborn Screening for Spinal Muscular Atrophy in Serbia
by: Miloš Brkušanin, et al.
Published: (2024-08-01)

Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening
by: Regina Trollmann, et al.
Published: (2024-09-01)

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesResearch in context
by: Marika Pane, et al.
Published: (2023-05-01)

Early Development of Spinal Deformities in Children Severely Affected with Spinal Muscular Atrophy after Gene Therapy with Onasemnogene Abeparvovec—Preliminary Results
by: Venla Soini, et al.
Published: (2023-06-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
by: Fabián Lombillo, et al.
Published: (2019-05-01)

Innovating spinal muscular atrophy models in the therapeutic era
by: Ilaria Signoria, et al.
Published: (2023-09-01)

Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (1990-02-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-01-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-07-01)

Clinical Practice Guideline for Adolescent & Adult Patients with Spinal Muscular Atrophy
by: Rare Disease Society of Chinese Research Hospital Association, et al.
Published: (2023-04-01)

CDC’s Laboratory Activities to Support Newborn Screening for Spinal Muscular Atrophy
by: Francis K. Lee, et al.
Published: (2024-07-01)

Spinal muscular atrophy: a perspective outlook
by: M. R. Shaimurzin, et al.
Published: (2020-12-01)

Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in Ningde City, Fujian Province
by: JiaoJiao Lu, et al.
Published: (2025-02-01)

Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region
by: Ekaterina S. Novikova
Published: (2023-09-01)

Spinal Muscular Atrophy With Myoclonic Epilepsy
by: Buket ÖZKARA, et al.
Published: (2017-04-01)